CytoDyn Releases Regulatory FD Disclosure Information
Company Announcements

CytoDyn Releases Regulatory FD Disclosure Information

CytoDyn (CYDY) has released an update to notify the public and investors about a regulation fd disclosure.

The company has issued a press release on January 29, 2024, which is provided in relation to the information detailed in Item 5.02 of this report.

For further insights into CYDY stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyCytoDyn appoints Melissa Palmer as lead consultant in hepatology
TheFlyCytoDyn appoints Max Lataillade as head of clinical development
TheFlyCytoDyn engages Syneos Health as CRO for Phase II oncology trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App